ANF-like peptide(s) in the peripheral autonomic nervous system.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 3004433)

Published in Biochem Biophys Res Commun on January 14, 1986

Authors

W Debinski, J Gutkowska, O Kuchel, K Racz, N T Buu, M Cantin, J Genest

Articles by these authors

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet (1999) 7.30

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med (1999) 3.63

Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol (2001) 2.19

Pseudopheochromocytoma. Hypertension (1985) 2.15

Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet (1999) 2.02

The heart and the atrial natriuretic factor. Endocr Rev (1985) 1.99

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest (2000) 1.98

Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88

THE EFFECTS OF INTRAVENOUS INFUSIONS OF VALINE-5 ANGIOTENSIN II AND OTHER PRESSOR AGENTS ON URINARY ELECTROLYTES AND CORTICOSTEROIDS, INCLUDING ALDOSTERONE. J Clin Invest (1961) 1.84

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71

Homocysteine and cardiovascular disease in diabetes mellitus. Atherosclerosis (2001) 1.69

Vascular calcifications in homozygote familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (2008) 1.67

Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr (1996) 1.67

Early experience with laparoscopic approach for adrenalectomy. Surgery (1993) 1.61

Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem Biophys Res Commun (1984) 1.59

Angiotensin-forming enzyme in brain tissue. Science (1971) 1.55

Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J Biol Chem (1995) 1.52

Percutaneous transluminal angioplasty in coronary-internal thoracic-subclavian steal syndrome. Can J Cardiol (1997) 1.46

Lipoprotein (a) blood levels in unstable angina pectoris, acute myocardial infarction, and after thrombolytic therapy. Am J Cardiol (1991) 1.41

Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem (1985) 1.41

Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene (2008) 1.41

Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable. Am J Hypertens (1993) 1.38

Has the CMA become "big business"? CMAJ (1990) 1.37

Production of insulin resistance by hyperinsulinaemia in man. Diabetologia (1985) 1.36

Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet (1995) 1.35

Measurement of renin in both renal veins. Its use in diagnosis of renovascular hypertension. Arch Intern Med (1967) 1.33

Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms. Proc Natl Acad Sci U S A (1984) 1.28

Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26

Atrial natriuretic factor is a circulating hormone. Biochem Biophys Res Commun (1984) 1.26

Renin-aldosterone system in Parkinson's disease. Science (1969) 1.26

Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system. J Biol Chem (1990) 1.22

Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells. Endocrinology (1984) 1.22

Phenylpropanolamine, stroke and hypertension. CMAJ (2001) 1.21

The atrial natriuretic factor: its physiology and biochemistry. Rev Physiol Biochem Pharmacol (1988) 1.20

Role of the adrenal cortex and sodium in the pathogenesis of human hypertension. Can Med Assoc J (1978) 1.19

Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry (1984) 1.19

Acute changes in plasma volume, renin activity, and free aldosterone levels in healthy subjects following Fursemide administration. Can J Physiol Pharmacol (1968) 1.18

Diurnal variation of plasma vasopressin in man. J Clin Endocrinol Metab (1975) 1.16

Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol (1984) 1.15

The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol (1997) 1.15

Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency. Curr Opin Lipidol (2000) 1.15

Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.14

Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis (1991) 1.14

Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A (1998) 1.13

Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. N Engl J Med (1985) 1.12

Renin in dog brain. Am J Physiol (1971) 1.12

Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aorta. Can Med Assoc J (1975) 1.12

High-density lipoproteins and endothelial function. Circulation (2001) 1.12

Direct radioimmunoassay of atrial natriuretic factor. Biochem Biophys Res Commun (1984) 1.11

Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci U S A (1995) 1.11

Relationship between the adrenergic nervous system and renin during adaptation to upright posture: a possible role for 3,4-dihydroxyphenethylamine (dopamine). Clin Sci (1972) 1.09

Relationship of specific granules to the natriuretic and diuretic activity of rat atria. Experientia (1982) 1.09

The renin-angiotensin system in newborn dogs. Can J Physiol Pharmacol (1971) 1.08

Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood (1996) 1.07

A micromethod for measurement of renin in the plasma and kidney of rats. Can J Physiol Pharmacol (1967) 1.07

Endocrine factors in congestive heart failure. Am J Cardiol (1968) 1.07

Effects of saline and albumin on plasma and urinary catecholamines in dogs. Am J Physiol (1977) 1.07

C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle. Biol Reprod (1997) 1.06

Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells. Biochem Biophys Res Commun (1997) 1.06

Some thoughts on residency training. Can Med Assoc J (1969) 1.06

Oxytocin and its receptors are synthesized in the rat vasculature. Proc Natl Acad Sci U S A (2000) 1.06

Clinical comparison of acoustic and electronic stethoscopes and design of a new electronic stethoscope. Am J Cardiol (1998) 1.06

Characterization of specific receptors for atrial natriuretic factor in bovine adrenal zona glomerulosa. Life Sci (1984) 1.06

Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein. Clin Cancer Res (1997) 1.06

A method for production of experimental hypertension in rats. Can J Physiol Pharmacol (1968) 1.05

Comments on the report on medicare (volume I) of the Castonguay Commission, province of Quebec. Can Med Assoc J (1967) 1.05

Primary structure of a high Mr form of rat atrial natriuretic factor. FEBS Lett (1984) 1.05

Hyperapobetalipoproteinemia. Plasma lipoprotein responses to oral fat load. Arteriosclerosis (1986) 1.03

Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Can Med Assoc J (1979) 1.03

Metaplasia of smooth muscle cells into juxtaglomerular cells in the juxtaglomerular apparatus, arteries, and arterioles of the ischemic (endocrine) kidney. An ultrastructural-cytochemical and autoradiographic study. Am J Pathol (1977) 1.03